Equity Compensation Plans

12 Months Ended

Dec. 31, 2019

Share-based Payment Arrangement [Abstract]

Equity Compensation Plans

Stock Option Plan

The Company maintains equity compensation plans that allow the Company’s Board of Directors to grant stock options and other equity awards to eligible employees, officers, directors and consultants.  On April 27, 2017, the Company’s shareholders voted to approve the Akorn, Inc. 2017 Omnibus Incentive Compensation Plan (the “Omnibus Plan”), setting aside 8.0 million shares of the Company’s common stock for issuance pursuant to equity awards. Subsequently, at the 2019 Annual Meeting of Shareholders on May 1, 2019, the Company’s shareholders approved a 4.4 million increase to the shares available for awards granted under the Omnibus Plan, raising the overall total to 12.4 million shares. The Omnibus Plan replaced the Akorn, Inc. 2014 Stock Option Plan (the “2014 Plan”), which was approved at the Company's 2014 Annual Meeting of Shareholders on May 2, 2014 and subsequently amended by proxy vote of the Company’s shareholders on December 16, 2016. The 2014 Plan had reserved 7.5 million shares for issuance upon the grant of stock options, restricted stock units (“RSUs”), performance share unit awards (“PSUs”) or various other instruments to employees, officers, directors and consultants.  Following shareholder approval of the Omnibus Plan, no new awards could be granted under the 2014 Plan, although previously granted awards remain outstanding pursuant to their original terms.

As of December 31, 2019, there were approximately 2.1 million stock options and thirty-three thousand two hundred RSU shares outstanding under the 2014 Plan.

Under the Omnibus Plan, there were approximately 4.5 million RSU shares, 1.0 million PSU shares and 2.7 million stock option award shares outstanding as of December 31, 2019. As of December 31, 2019, approximately 3.3 million shares remained available for future award grants under the Omnibus Plan.

Also granted in, and outstanding as of the year ended December 31, 2019, were inducement awards consisting of 0.5 million RSU shares, 0.3 million PSU shares and 0.4 million stock option award shares.

The Company accounts for stock-based compensation in accordance with ASC Topic 718 - Compensation — Stock Compensation. Accordingly, stock-based compensation cost for stock options and RSUs is estimated at the grant date based on the fair value of the award, and the cost is recognized as expense ratably over the vesting period. The Company uses the Black-Scholes model for estimating the grant date fair value of stock options. Determining the assumptions that enter into the model is highly subjective and requires judgment. The Company uses an expected volatility that is based on the historical volatility of its stock. The expected life assumption is based on historical employee exercise patterns and employee post-vesting termination behavior. The risk-free interest rate for the expected term of the option is based on the market rates on U.S. Treasury securities in effect during the quarter in which the options were granted. The dividend yield reflects historical experience as well as future expectations over the expected term of the option. The Company estimates forfeitures at the time of grant and revises in subsequent periods, as necessary, if actual forfeitures differ from those estimates.

All RSUs are valued at the closing market price of the Company’s common stock on the day of grant and the total value of the units is recognized as expense ratably over the vesting period of the grant. PSU awards granted with vesting subject to market conditions are valued at date of grant through a Monte Carlo simulation model. The calculated grant-date fair value is recognized ratably over the vesting period, subject to forfeiture estimates. PSU awards granted with vesting subject to, and determined based on achievement of, performance conditions are valued at date of grant based on the closing price of the Company’s stock and anticipated vesting level at grant date. The awards are re-evaluated quarterly to determine the vesting level that is more likely than not to be achieved, and cumulative expense is adjusted accordingly.

The Company recorded stock-based compensation expense of approximately $21.3 million, $21.5 million and $21.0 million during the years ended December 31, 2019, 2018 and 2017, respectively.

Stock Option Awards

From time to time, the Company has granted stock option awards to certain employees, executives and directors. The assumptions used in estimating the fair value of the stock options granted during the period, along with the weighted-average grant date fair values, were as follows:

	2019	2018	2017
Expected volatility	56.5%	—%	49.5%
Expected life (in years)	6.3	0	4.8
Risk-free interest rate	2.3%	—%	1.7%
Dividend yield	—	N/A	—
Weighted-average grant date fair value per stock option	$2.33	N/A	$9.25
Forfeiture rate	8.0%	—%	8.0%

The table below sets forth a summary of stock option activity within the Company’s stock-based compensation plans for the years ended December 31, 2019, 2018 and 2017:

	Number of Shares (in thousands)		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (in thousands) (1)
Outstanding at December 31, 2016	4,766		$	27.27
Granted	66		21.28
Exercised	(623	)	15.53
Forfeited or expired	(156	)	28.2
Outstanding at December 31, 2017	4,053		$	28.95
Granted	—		—
Exercised	(22	)	24.99
Forfeited or expired	(613	)	31.28
Outstanding at December 31, 2018	3,418		$	28.55
Granted	3,237		4.24
Exercised	—		—
Forfeited or expired	(1,451	)	25.31
Outstanding at December 31, 2019	5,204		$	14.33	6.8	$	—
Exercisable at December 31, 2019	1,808		$	30.20	3.0	$	—

(1) Includes only those options that were in-the-money as of December 31, 2019. Stock options for which the exercise price exceeded the market price have been omitted. Fluctuations in the intrinsic value of both outstanding and exercisable options may result from changes in underlying stock price and the timing and volume of option grants, exercises and forfeitures.

The aggregate intrinsic value for stock options outstanding and exercisable is defined as the difference between the market value of the Company’s common stock at the end of the period and the exercise price of stock options. No stock options were exercised during the year ended December 31, 2019. The total intrinsic value of stock options exercised during the years ended December 31, 2018 and 2017, was approximately $0.2 million and $9.8 million, respectively. As a result of the stock options exercised, the Company received cash and recorded additional paid-in-capital of approximately $0.5 million and $9.7 million during the years ended December 31, 2018 and 2017, respectively.

As of December 31, 2019, the total amount of unrecognized compensation cost related to non-vested stock options was approximately $7.2 million, which is expected to be recognized as expense over a weighted-average period of 2.9 years.

Restricted Stock Unit Awards

From time to time, the Company has granted RSUs to certain employees, executives and directors. Historically, the majority of RSU grants to employees and executives have been pursuant to the Company's long-term incentive plans (the “LTIPs”), which allow for annual grants of RSUs to all eligible employees and executives. The RSU awards vest 25% per year on each of the first four anniversaries of the grant date. During the year ended December 31, 2019, the Company granted 4.4 million RSUs to certain employees, executives and directors. Of this total, 2.4 million RSUs were granted to certain employees as a retention incentive under the Omnibus Plan, and vest in full two years after grant date. Another 1.0 million RSUs were granted as LTIP and annual Director awards under the Omnibus Plan, 0.5 million RSUs were granted to executive new hires and 0.5 million RSUs were granted as an inducement award to the Company’s new President and Chief Executive Officer (“CEO”).

Set forth below is a summary of unvested RSU activity for the three years ended December 31, 2019, 2018 and 2017:

	Number of Shares (in thousands)		Weighted Average per Share Grant Date Fair Value
Unvested at December 31, 2016	416		$	31.52
Granted	666		33.10
Vested	(137	)	32.55
Forfeited	(57	)	31.34
Unvested at December 31, 2017	888		$	32.55
Granted (1)	1,711		16.07
Vested	(408	)	30.22
Forfeited (1)	(548	)	24.00
Unvested at December 31, 2018	1,643		$	19.85
Granted	4,432		4.10
Vested	(631	)	24.10
Forfeited	(370	)	14.11
Unvested at December 31, 2019	5,074		$	7.07

(1) RSUs granted and forfeited during 2018 include 0.4 million RSUs held by the Company’s former CEO and COO that were modified to accelerate vesting. This modification was treated as forfeiture of the old awards and granting of new awards with modified vesting terms.

As of December 31, 2019, the total amount of unrecognized compensation cost related to RSU awards was approximately $24.9 million which is expected to be recognized as expense over a weighted-average period of 2.1 years.

Performance Share Unit awards

As of December 31, 2019, 1.2 million PSU award shares were granted to certain executives. Of this total, 1.0 million vest two years after grant with vesting level contingent upon meeting various performance conditions, while the remaining 0.2 million vest four years after grant with vesting level contingent on various market conditions. No PSU awards were granted by the Company prior to 2019.

Set forth below is a summary of unvested PSU activity for the year ended December 31, 2019:

	Total Number of Units (in thousands)		Weighted Average Grant Date Fair Value per Unit		Vesting Based on Performance Conditions		Weighted Average Grant Date Fair Value per Unit		Vesting Based on Market Conditions	Weighted Average Grant Date Fair Value per Unit
Unvested at December 31, 2018	—		$	—	—		$	—	—	$	—
Granted	1,239		$	3.99	985		$	4.06	254	$	3.73
Vested	—		$	3.99	—		$	—	—	$	—
Forfeited	(21	)	$	4.06	(21	)	$	4.06	—	$	3.73
Unvested at December 31, 2019	1,218		$	3.99	964		$	4.06	254	$	3.73

As of December 31, 2019, the total amount of unrecognized compensation cost related to PSU awards was approximately $2.6 million which is expected to be recognized as expense over a weighted-average period of 1.6 years.

Set forth below is a summary of the valuation inputs for PSUs granted with vesting subject to market conditions for the year ended December 31, 2019:

Valuation Inputs for PSUs with Vesting Subject to Market Conditions:
PSUs Issued (units in thousands)	254
Risk Free Rate	2.6		%
Volatility	55.1		%
Dividend	—
Valuation per Share	$	3.73
Total Fair Value (in thousands)	$	947
Expected Term	4 years
Forfeiture Rate Assumed	8.0		%

LTIP Cash awards

In May 2019, the Company awarded $9.7 million in cash-based awards to certain non-executive employees in lieu of the customary RSUs as part of its 2019 LTIP grants. The cash awards are equivalent to the value of RSUs that would have been granted under the previous program design and will vest over two years and be paid in two equal installments after each of the first two anniversaries of the grant date. During the year ended December 31, 2019, the Company recorded $2.8 million in expense, net of forfeitures.

Employee Stock Purchase Plan

The 2016 Akorn, Inc. Employee Stock Purchase Plan (the “ESPP”) permits eligible employees to acquire shares of the Company’s common stock through payroll deductions.  The ESPP has been structured to qualify under Section 423 of the Internal Revenue Code (“IRC”).  Employees who elect to participate in the ESPP may withhold from 1% to 15% of eligible wages toward the purchase of stock.  Shares will be purchased at a 15% discount off the lesser of the market price at the beginning or the ending of the applicable offering period.  The ESPP is designed with two offering periods each year, one running from January 1st to December 31st and the other running from July 1st to December 31st.  In a given year, employees may enroll in only one offering period, not both.  Per IRC rules, annual purchases per employee are limited to $25,000 worth of stock, valued as of the beginning of the offering period.  Accordingly, with the 15% discount, employees may withhold no more than $21,250 per year toward the purchase of stock under the ESPP. Employees are further limited to purchasing no more than 15,000 shares of stock per year. A total of 2.0 million shares of the Company’s stock have been set aside for issuance under the ESPP. The ESPP was approved by vote of the Company’s shareholders on December 16, 2016.

The initial offering period under the ESPP began in January 2017 and ran through the end of 2017. The Company did not have an ESPP offering period starting on July 1, 2017 and did not have any offering periods in 2018 pursuant to terms of the

Merger Agreement. During the year ended December 31, 2017, participants contributed approximately $2.8 million through payroll deductions toward the purchase of shares under the ESPP. The Company recorded stock-based compensation expense of $1.1 million during the year ended December 31, 2017 related to the ESPP.

The Company initiated two offering periods during 2019, one starting on February 1, 2019 and the second starting on July 1, 2019. However, the Company suspended the ESPP during the quarter ended December 31, 2019 and refunded all accumulated contributions.

For the year ended December 31, 2019, the Company recorded approximately $1.3 million in stock-based compensation expense related to the ESPP. In accordance with ASC 718, Compensation - Stock Compensation, the suspension of an ESPP does not result in reversal of previously recorded stock-based compensation expense, but rather an acceleration of the remaining unrecognized expense.

A total of 2.0 million shares of stock were set aside for issuance under the ESPP. Participants in the 2017 offering period acquired a total of 0.1 million shares. As of December 31, 2019, 1.9 million shares remain available for future issuance under the ESPP.